Free Trial

Adaptimmune Therapeutics (ADAP) Income Statement & Balance Sheet

Adaptimmune Therapeutics logo
$0.59 -0.01 (-0.91%)
As of 04:00 PM Eastern

Adaptimmune Therapeutics Income Statement, Balance Sheet and Cash Flow Statement



This page (NASDAQ:ADAP) was last updated on 1/14/2025 by MarketBeat.com Staff
From Our Partners